NCT06833073
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06833073
Title A Clinical Study of V940 and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Acronym V940-011/​INTerpath-011
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ESP | BRA | AUS | ARG


No variant requirements are available.